Devyser. A new level of certainty We’re specialists when it comes to diagnostic kits for complex DNA testing within oncology, hereditary diseases and transplantation. Our products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, as well as in post transplant follow-up. We have a guiding principle when it comes to developing products that are ideal for routine diagnostics: make the technology simple, reproducible and less prone to user-generated errors. And this is precisely what our customers appreciate about us, which is why routine diagnostic laboratories in more than 60 countries worldwide use our products.
View Top Employees from DevyserWebsite | https://www.devyser.com |
Revenue | $17.3 million |
Funding | $900000 |
Employees | 119 (104 on RocketReach) |
Founded | 2004 |
Phone | +46 8 562 158 50 |
Technologies |
JavaScript,
HTML,
Twitter
+29 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services |
Web Rank | 3 Million |
Keywords | Oncology, Targeted Cancer Therapies |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Devyser employee's phone or email?
The Devyser annual revenue was $17.3 million in 2024.
Sabina Berlin is the CFO of Devyser.
104 people are employed at Devyser.
The NAICS codes for Devyser are [5417, 541713, 541, 54171, 54].
The SIC codes for Devyser are [87, 873].